Michael Schmidt
Stock Analyst at Guggenheim
(3.98)
# 561
Out of 4,944 analysts
114
Total ratings
56.18%
Success rate
9.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Schmidt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Reiterates: Buy | $18 | $10.11 | +78.04% | 6 | Aug 13, 2025 | |
| CMPX Compass Therapeutics | Maintains: Buy | $10 → $12 | $3.24 | +270.37% | 5 | Aug 12, 2025 | |
| ONC BeOne Medicines | Maintains: Buy | $350 → $365 | $299.97 | +21.68% | 4 | Aug 7, 2025 | |
| ARVN Arvinas | Maintains: Buy | $16 → $15 | $7.14 | +110.08% | 6 | Aug 7, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $10 | $6.69 | +49.48% | 1 | Aug 6, 2025 | |
| COGT Cogent Biosciences | Reiterates: Buy | $17 | $11.67 | +45.67% | 1 | Jul 8, 2025 | |
| RVMD Revolution Medicines | Reiterates: Buy | $80 | $35.12 | +127.79% | 4 | Jun 25, 2025 | |
| AVBP ArriVent BioPharma | Reiterates: Buy | $45 | $16.80 | +167.86% | 2 | Jun 24, 2025 | |
| ADCT ADC Therapeutics | Maintains: Buy | $7 → $10 | $3.00 | +233.33% | 5 | Jun 13, 2025 | |
| URGN UroGen Pharma | Maintains: Buy | $40 → $15 | $19.29 | -22.24% | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $5.59 | +2,136.14% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $39.93 | +30.23% | 1 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $3.45 | +189.86% | 1 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $13.30 | +140.60% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $8.25 | -3.03% | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $63.91 | +70.55% | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $1.75 | $0.08 | +2,118.00% | 3 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $8.44 | +65.88% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $25 | $10.12 | +147.04% | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $92 | $83.49 | +10.20% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $37.33 | - | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $38.00 | +10.53% | 10 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.52 | - | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.16 | +533.19% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $1.45 | +451.72% | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.10 | - | 3 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.51 | - | 2 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.15 | - | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.05 | - | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $7.92 | +329.56% | 4 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $0.66 | +2,934.90% | 3 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $22.33 | - | 2 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $1.58 | +1,482.28% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $4.51 | +565.19% | 1 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $3.47 | +648.59% | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.82 | - | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $80 | $35.76 | +123.71% | 5 | Feb 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.09 | - | 6 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $4 → $5.5 | $3.40 | +61.76% | 2 | Nov 7, 2017 |
ORIC Pharmaceuticals
Aug 13, 2025
Reiterates: Buy
Price Target: $18
Current: $10.11
Upside: +78.04%
Compass Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $3.24
Upside: +270.37%
BeOne Medicines
Aug 7, 2025
Maintains: Buy
Price Target: $350 → $365
Current: $299.97
Upside: +21.68%
Arvinas
Aug 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $7.14
Upside: +110.08%
Tango Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $10
Current: $6.69
Upside: +49.48%
Cogent Biosciences
Jul 8, 2025
Reiterates: Buy
Price Target: $17
Current: $11.67
Upside: +45.67%
Revolution Medicines
Jun 25, 2025
Reiterates: Buy
Price Target: $80
Current: $35.12
Upside: +127.79%
ArriVent BioPharma
Jun 24, 2025
Reiterates: Buy
Price Target: $45
Current: $16.80
Upside: +167.86%
ADC Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $3.00
Upside: +233.33%
UroGen Pharma
May 23, 2025
Maintains: Buy
Price Target: $40 → $15
Current: $19.29
Upside: -22.24%
May 16, 2025
Reiterates: Buy
Price Target: $125
Current: $5.59
Upside: +2,136.14%
May 12, 2025
Reiterates: Buy
Price Target: $52
Current: $39.93
Upside: +30.23%
May 7, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.45
Upside: +189.86%
May 6, 2025
Reiterates: Buy
Price Target: $32
Current: $13.30
Upside: +140.60%
Apr 4, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $8.25
Upside: -3.03%
Mar 28, 2025
Reiterates: Buy
Price Target: $109
Current: $63.91
Upside: +70.55%
Mar 26, 2025
Maintains: Buy
Price Target: $3 → $1.75
Current: $0.08
Upside: +2,118.00%
Mar 24, 2025
Maintains: Buy
Price Target: $13 → $14
Current: $8.44
Upside: +65.88%
Mar 20, 2025
Maintains: Buy
Price Target: $35 → $25
Current: $10.12
Upside: +147.04%
Mar 18, 2025
Downgrades: Neutral
Price Target: $92
Current: $83.49
Upside: +10.20%
Mar 12, 2025
Reiterates: Neutral
Price Target: n/a
Current: $37.33
Upside: -
Feb 12, 2025
Reiterates: Buy
Price Target: $42
Current: $38.00
Upside: +10.53%
Jan 22, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.52
Upside: -
Dec 6, 2024
Reiterates: Buy
Price Target: $20
Current: $3.16
Upside: +533.19%
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $1.45
Upside: +451.72%
Oct 7, 2024
Downgrades: Neutral
Price Target: n/a
Current: $32.10
Upside: -
May 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.51
Upside: -
Mar 14, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.15
Upside: -
Jan 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.05
Upside: -
Nov 8, 2023
Maintains: Buy
Price Target: $40 → $34
Current: $7.92
Upside: +329.56%
Jun 27, 2023
Downgrades: Neutral
Price Target: $20
Current: $0.66
Upside: +2,934.90%
Jan 3, 2022
Downgrades: Neutral
Price Target: n/a
Current: $22.33
Upside: -
Aug 10, 2021
Initiates: Buy
Price Target: $25
Current: $1.58
Upside: +1,482.28%
Jul 19, 2021
Initiates: Buy
Price Target: $30
Current: $4.51
Upside: +565.19%
May 18, 2021
Initiates: Buy
Price Target: $26
Current: $3.47
Upside: +648.59%
Apr 28, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.82
Upside: -
Feb 15, 2019
Upgrades: Outperform
Price Target: $80
Current: $35.76
Upside: +123.71%
Jan 17, 2019
Initiates: Outperform
Price Target: n/a
Current: $6.09
Upside: -
Nov 7, 2017
Maintains: Market Perform
Price Target: $4 → $5.5
Current: $3.40
Upside: +61.76%